Sfoglia per Autore
The gut barrier: New acquisitions and therapeutic approaches
2012-01-01 Scaldaferri, F.; Pizzoferrato, M.; Gerardi, V.; Lopetuso, L.; Gasbarrini, A.
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
2012-01-01 Lopetuso, L. R.; Scaldaferri, F.; Pizarro, T. T.
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide
2012-01-01 Forte, F.; Pizzoferrato, M.; Lopetuso, L.; Scaldaferri, F.
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice
2013-01-01 Lopetuso, L. R.; Petito, V.; Cufino, V.; Arena, V.; Stigliano, E.; Gerardi, V.; Gaetani, E.; Poscia, A.; Amato, A.; Cammarota, G.; Papa, A.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F.
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system
2013-01-01 Kodani, T.; Rodriguez-Palacios, A.; Corridoni, D.; Lopetuso, L.; Di Martino, L.; Marks, B.; Pizarro, J.; Pizarro, T.; Chak, A.; Cominelli, F.
Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility
2013-01-01 Scaldaferri, F.; Gerardi, V.; Lopetuso, L. R.; Del Zompo, F.; Mangiola, F.; Boškoski, I.; Bruno, G.; Petito, V.; Laterza, L.; Cammarota, G.; Gaetani, E.; Sgambato, A.; Gasbarrini, A.
Tricks for interpreting and making a good report on hydrogen and 13C breath tests
2013-01-01 D'Angelo, G.; Di Rienzo, T. A.; Scaldaferri, F.; Del Zompo, F.; Pizzoferrato, M.; Lopetuso, L. R.; Laterza, L.; Bruno, G.; Petito, V.; Campanale, M. C.; Cesario, V.; Franceschi, F.; Cammarota, G.; Gaetani, E.; Gasbarrini, A.; Ojetti, V.
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation
2013-01-01 Pizzoferrato, M.; Del Zompo, F.; Mangiola, F.; Lopetuso, L. R.; Petito, V.; Cammarota, G.; Gasbarrini, A.; Scaldaferri, F.
Opposing functions of classic and novel IL-1 family members in gut health and disease
2013-01-01 Lopetuso, L. R.; Chowdhry, S.; Pizarro, T. T.
Commensal Clostridia: Leading players in the maintenance of gut homeostasis
2013-01-01 Lopetuso, L. R.; Scaldaferri, F.; Petito, V.; Gasbarrini, A.
13C-octanoic acid breath test to study gastric emptying time
2013-01-01 Bruno, G.; Lopetuso, L. R.; Ianiro, G.; Laterza, L.; Gerardi, V.; Petito, V.; Poscia, A.; Gasbarrini, A.; Ojetti, V.; Scaldaferri, F.
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives
2013-01-01 Scaldaferri, F.; Petito, V.; Lopetuso, L.; Bruno, G.; Gerardi, V.; Ianiro, G.; Sgambato, A.; Gasbarrini, A.; Cammarota, G.
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication
2013-01-01 Scaldaferri, F.; Nardone, O.; Lopetuso, L. R.; Petito, V.; Bibbò, S.; Laterza, L.; Gerardi, V.; Bruno, G.; Scoleri, I.; Diroma, A.; Sgambato, A.; Gaetani, E.; Cammarota, G.; Gasbarrini, A.
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression?
2014-01-01 Scaldaferri, F.; Petito, V.; Papa, A.; Cesarini, M.; Arena, V.; Lopetuso, L. R.; Corbi, M.; Perino, F.; Caldarola, G.; Carbone, A.; Corazziari, E.; Sgambato, A.; Gasbarrini, A.; De Simone, C.
Role of yeasts in healthy and impaired gut microbiota: The gut mycome
2014-01-01 Ianiro, G.; Bruno, G.; Lopetuso, L.; Beghella, F. B.; Laterza, L.; D'Aversa, F.; Gigante, G.; Cammarota, G.; Gasbarrini, A.
The gastrointestinal microbiome - Functional interference between stomach and intestine
2014-01-01 Lopetuso, L. R.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A.
Role of microbiota and innate immunity in recurrent clostridium difficile infection
2014-01-01 Bibbò, S.; Lopetuso, L. R.; Ianiro, G.; Di Rienzo, T.; Gasbarrini, A.; Cammarota, G.
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD?
2014-01-01 Scaldaferri, F.; Lopetuso, L. R.; Petito, V.; Cufino, V.; Bilotta, M.; Arena, V.; Stigliano, E.; Maulucci, G.; Papi, M.; Emiliana, C. M.; Poscia, A.; Franceschi, F.; Delogu, G.; Sanguinetti, M.; de Spirito, M.; Sgambato, A.; Gasbarrini, A.
Role of Helicobacter pylori infection on nutrition and metabolism
2014-01-01 Franceschi, F.; Tortora, A.; Di Rienzo, T.; D'Angelo, G.; Ianiro, G.; Scaldaferri, F.; Gerardi, V.; Tesori, V.; Lopetuso, L. R.; Gasbarrini, A.
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
2015-01-01 Ponziani, F. R.; Gerardi, V.; Pecere, S.; D'Aversa, F.; Lopetuso, L.; Zocco, M. A.; Pompili, M.; Gasbarrini, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The gut barrier: New acquisitions and therapeutic approaches | 2012 | Scaldaferri, F.; Pizzoferrato, M.; Gerardi, V.; Lopetuso, L.; Gasbarrini, A. | |
| Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis | 2012 | Lopetuso, L. R.; Scaldaferri, F.; Pizarro, T. T. | |
| The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide | 2012 | Forte, F.; Pizzoferrato, M.; Lopetuso, L.; Scaldaferri, F. | |
| Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice | 2013 | Lopetuso, L. R.; Petito, V.; Cufino, V.; Arena, V.; Stigliano, E.; Gerardi, V.; Gaetani, E.; Poscia, A.; Amato, A.; Cammarota, G.; Papa, A.; Sgambato, A.; Gasbarrini, A.; Scaldaferri, F. | |
| Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system | 2013 | Kodani, T.; Rodriguez-Palacios, A.; Corridoni, D.; Lopetuso, L.; Di Martino, L.; Marks, B.; Pizarro, J.; Pizarro, T.; Chak, A.; Cominelli, F. | |
| Gut microbial flora, prebiotics, and probiotics in IBD: Their current usage and utility | 2013 | Scaldaferri, F.; Gerardi, V.; Lopetuso, L. R.; Del Zompo, F.; Mangiola, F.; Boškoski, I.; Bruno, G.; Petito, V.; Laterza, L.; Cammarota, G.; Gaetani, E.; Sgambato, A.; Gasbarrini, A. | |
| Tricks for interpreting and making a good report on hydrogen and 13C breath tests | 2013 | D'Angelo, G.; Di Rienzo, T. A.; Scaldaferri, F.; Del Zompo, F.; Pizzoferrato, M.; Lopetuso, L. R.; Laterza, L.; Bruno, G.; Petito, V.; Campanale, M. C.; Cesario, V.; Franceschi, F.; Cammarota, G.; Gaetani, E.; Gasbarrini, A.; Ojetti, V. | |
| Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation | 2013 | Pizzoferrato, M.; Del Zompo, F.; Mangiola, F.; Lopetuso, L. R.; Petito, V.; Cammarota, G.; Gasbarrini, A.; Scaldaferri, F. | |
| Opposing functions of classic and novel IL-1 family members in gut health and disease | 2013 | Lopetuso, L. R.; Chowdhry, S.; Pizarro, T. T. | |
| Commensal Clostridia: Leading players in the maintenance of gut homeostasis | 2013 | Lopetuso, L. R.; Scaldaferri, F.; Petito, V.; Gasbarrini, A. | |
| 13C-octanoic acid breath test to study gastric emptying time | 2013 | Bruno, G.; Lopetuso, L. R.; Ianiro, G.; Laterza, L.; Gerardi, V.; Petito, V.; Poscia, A.; Gasbarrini, A.; Ojetti, V.; Scaldaferri, F. | |
| Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives | 2013 | Scaldaferri, F.; Petito, V.; Lopetuso, L.; Bruno, G.; Gerardi, V.; Ianiro, G.; Sgambato, A.; Gasbarrini, A.; Cammarota, G. | |
| Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication | 2013 | Scaldaferri, F.; Nardone, O.; Lopetuso, L. R.; Petito, V.; Bibbò, S.; Laterza, L.; Gerardi, V.; Bruno, G.; Scoleri, I.; Diroma, A.; Sgambato, A.; Gaetani, E.; Cammarota, G.; Gasbarrini, A. | |
| Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? | 2014 | Scaldaferri, F.; Petito, V.; Papa, A.; Cesarini, M.; Arena, V.; Lopetuso, L. R.; Corbi, M.; Perino, F.; Caldarola, G.; Carbone, A.; Corazziari, E.; Sgambato, A.; Gasbarrini, A.; De Simone, C. | |
| Role of yeasts in healthy and impaired gut microbiota: The gut mycome | 2014 | Ianiro, G.; Bruno, G.; Lopetuso, L.; Beghella, F. B.; Laterza, L.; D'Aversa, F.; Gigante, G.; Cammarota, G.; Gasbarrini, A. | |
| The gastrointestinal microbiome - Functional interference between stomach and intestine | 2014 | Lopetuso, L. R.; Scaldaferri, F.; Franceschi, F.; Gasbarrini, A. | |
| Role of microbiota and innate immunity in recurrent clostridium difficile infection | 2014 | Bibbò, S.; Lopetuso, L. R.; Ianiro, G.; Di Rienzo, T.; Gasbarrini, A.; Cammarota, G. | |
| Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? | 2014 | Scaldaferri, F.; Lopetuso, L. R.; Petito, V.; Cufino, V.; Bilotta, M.; Arena, V.; Stigliano, E.; Maulucci, G.; Papi, M.; Emiliana, C. M.; Poscia, A.; Franceschi, F.; Delogu, G.; Sanguinetti, M.; de Spirito, M.; Sgambato, A.; Gasbarrini, A. | |
| Role of Helicobacter pylori infection on nutrition and metabolism | 2014 | Franceschi, F.; Tortora, A.; Di Rienzo, T.; D'Angelo, G.; Ianiro, G.; Scaldaferri, F.; Gerardi, V.; Tesori, V.; Lopetuso, L. R.; Gasbarrini, A. | |
| Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications | 2015 | Ponziani, F. R.; Gerardi, V.; Pecere, S.; D'Aversa, F.; Lopetuso, L.; Zocco, M. A.; Pompili, M.; Gasbarrini, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile